Recent Drug Withdrawals Had Greater Health Risks For Women - GAO Report
Executive Summary
Eight of 10 prescription drugs withdrawn from the market since Jan. 1, 1997 presented more significant health risks for women than men, a General Accounting Office report finds.
You may also be interested in...
Women Enrollment In Phase I/II Trials Continues To Be Low, GAO Says
Women continue to be under-represented in early phase safety studies, a General Accounting Office report on women in clinical trials suggests.
Senate HHS Approps Chair Harkin Looking At FDA Rules On Women In Trials
The representation of women in clinical trials will be a likely hearing topic for the Senate Appropriations/Labor, HHS & Education Subcommittee under incoming Chairman Harkin (D-Iowa).
Senate HHS Approps Chair Harkin Looking At FDA Rules On Women In Trials
The representation of women in clinical trials will be a likely hearing topic for the Senate Appropriations/Labor, HHS & Education Subcommittee under incoming Chairman Harkin (D-Iowa).